Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Nurse Educator|July 19, 2023
Prebrief Time for Immersive Virtual and Augmented Reality Simulation: An Integrative ReviewBethany J Cieslowski, Sarah Craig, Sai Deepthi Gummadi, et al.Nursing Education Perspectives|February 2, 2023
Telepresence: An Innovative Teaching Modality to Enrich Simulation and Remote LearningDavid R Want, Bethany J CieslowskiNurse Education Today|October 23, 2020
Simulation strategies to increase nursing student clinical competence in safe medication administration practices: A quasi-experimental studySarah J Craig, Jennifer C Kastello, Bethany J Cieslowski, et al.Journal of Clinical Pharmacology|October 8, 2010
Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with mild hepatic impairmentKathleen Butler, Renli TengEuropean Journal of Clinical Pharmacology|January 22, 2010
Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjectsRenli Teng, Kathleen ButlerClinical Therapeutics|July 23, 2013
The effect of ticagrelor on the metabolism of midazolam in healthy volunteersRenli Teng, Kathleen ButlerEuropean Journal of Clinical Pharmacology|June 11, 2013
A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteersRenli Teng, Kathleen ButlerCurrent Medical Research and Opinion|June 23, 2011
Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteersKathleen Butler, Renli TengInternational Journal of Clinical Pharmacology and Therapeutics|September 18, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics of high single-ascending doses of ticagrelor in healthy volunteersRenli Teng, Kathleen ButlerJournal of Clinical Pharmacology|October 1, 2011
Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairmentKathleen Butler, Renli TengPageof 8